Press Lab Current Research Grants and Funders

Grants

• Anti-CD20 CTL for Therapy of Mantle Cell Lymphoma
• CD45 Pretargeted Radioimmunotherapy for Acute Myelogenous Leukemia
• Pretargeted Radioimmunotherapy of CD20+ Non-Hodgkin's Lymphoma
• Therapy of Leukemia/Lymphoma with Monoclonal Antibodies
• Improved Targeting Strategies
• Radiolabeled Antibody Therapy of B-Cell Lymphoma
• Radiolabeled Antibody Therapy of Myelodysplasia and Acute Myelogenous Leukemia
• Radioimmunotherapy with Non-myeloablative Allogeneic Transplantation
• Proapoptotic Therapy for B-Cell Non Hodgkin's Lymphoma
• Optimizing adoptive T cell immunotherapy for Mantle Cell Lymphoma
• CD-20 Producing Lymphomas
• DOTA-Biotin for Pretargeted Radioimmunotherapy

Funders

Dr. Oliver W. Press and his entire group extend their thanks to the following organizations and individuals who have supported our research recently.

• National Cancer Institute, National Institutes of Health
• Lymphoma Research Foundation
• Leukemia and Lymphoma Society
• James & Sherry Raisbeck
• Edson Foundation
• Geary & Mary Britton-Simmons
• David & Patricia Giuliani
• Jane Hext, Hext Family Foundation
• Daniel M. Wyner, Wyner/Stokes Foundation
• Sharon E. Sigesmund
• Mike McCann, McCann Motors
• Donald Hunkins
• Rita and Arlyn Lawrence
• Mr. and Mrs. Gerald L. Coe
• Nancy L. Brandy-Phillips
• Shirley Kennedy
• Margaret Houlding
• Florence Faye Schwartz
• Diane Silven